ASHPOfficial

Therapeutics Thursday (SCSS): Out of this World: Hemgenix® (etranacogene dezaparvovec), the Recently Approved Gene Therapy for Hemophilia B and the Most Expensive Drug in the World!

11 Jun 2023

Audio

Description

Hemophilia B, also known as factor IX deficiency, is the second most common type of hemophilia. This podcast will discuss the limitations of current therapeutic options for Hemophilia B and explore the use of the new gene therapy, Hemgenix® (etranacogene dezaprarvovec), the most expensive drug in the world, from both a clinical and cost perspective. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes

🗳️ Sign in to Upvote

Popular episodes get transcribed faster

ASHPOfficial

Therapeutics Thursday (SCSS): Out of this World: Hemgenix® (etranacogene dezaparvovec), the Recently Approved Gene Therapy for Hemophilia B and the Most Expensive Drug in the World!

This episode hasn't been transcribed yet

Other recent transcribed episodes

3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE

13:00H | 21 DIC 2025 | Fin de Semana

12:00H | 21 DIC 2025 | Fin de Semana

10:00H | 21 DIC 2025 | Fin de Semana

13:00H | 20 DIC 2025 | Fin de Semana

12:00H | 20 DIC 2025 | Fin de Semana

Sign in to Audioscrape

Share this moment